KMPH Short Information, KemPharm Inc.
home / stock / kmph / kmph short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 1,199,897 |
| Total Actual Volume | 9,435,624 |
| Short Trends | |
|---|---|
| Cover Days | 1 |
| Short Days | 16 |
| No Change Days | 3 |
| Averages | |
|---|---|
| Average Short Volume | 59,995 |
| Average Short Percentage | 59.88% |
Is there a KMPH Short Squeeze or Breakout about to happen?
See the KMPH Short Analysis for free Sign up or Login
Powered by Squeeze Report
KMPH Twenty Trading Day's Volume to Short Volume Chart
KMPH Twenty Trading Day Price Chart
KMPH Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-06-28 | 4.71 | 4.52 | 4.79 | 4.52 | 212,708 | 16,981 | 30.2972 |
| 2022-06-24 | 4.67 | 4.65 | 4.77 | 4.26 | 3,874,163 | 147,695 | 67.5943 |
| 2022-06-23 | 4.47 | 4.63 | 4.65 | 4.39 | 297,326 | 37,168 | 51.9876 |
| 2022-06-22 | 4.36 | 4.46 | 4.67 | 4.3409 | 284,209 | 56,737 | 64.7905 |
| 2022-06-21 | 4.35 | 4.39 | 4.44 | 4.2 | 355,212 | 65,920 | 70.0033 |
| 2022-06-16 | 4.11 | 4.23 | 4.25 | 4.03 | 412,761 | 91,049 | 63.1080 |
| 2022-06-15 | 4.24 | 4.22 | 4.25 | 4.0701 | 252,658 | 37,771 | 54.3655 |
| 2022-06-14 | 4.34 | 4.14 | 4.35 | 4.11 | 216,058 | 38,485 | 53.6033 |
| 2022-06-13 | 4.25 | 4.32 | 4.34 | 4.1 | 429,123 | 81,777 | 52.5157 |
| 2022-06-09 | 4.86 | 4.85 | 4.96 | 4.78 | 212,552 | 34,965 | 65.7002 |
| 2022-06-08 | 4.99 | 4.89 | 5.11 | 4.88 | 274,457 | 44,360 | 54.3241 |
| 2022-06-06 | 4.75 | 4.72 | 4.89 | 4.66 | 325,047 | 76,986 | 74.1962 |
| 2022-06-03 | 4.69 | 4.72 | 4.8 | 4.56 | 234,017 | 38,682 | 47.1312 |
| 2022-06-02 | 4.57 | 4.73 | 4.77 | 4.5 | 226,089 | 51,315 | 58.0605 |
| 2022-06-01 | 4.64 | 4.57 | 4.705 | 4.49 | 257,033 | 95,623 | 91.6649 |
| 2022-05-31 | 4.72 | 4.63 | 4.8 | 4.58 | 355,422 | 81,025 | 75.2468 |
| 2022-05-26 | 4.53 | 4.6 | 4.65 | 4.5001 | 191,380 | 32,334 | 54.4894 |
| 2022-05-25 | 4.52 | 4.42 | 4.5392 | 4.32 | 286,473 | 69,371 | 75.5906 |
| 2022-05-24 | 4.66 | 4.52 | 4.67 | 4.47 | 308,351 | 36,706 | 46.9626 |
| 2022-05-23 | 4.9 | 4.69 | 4.9053 | 4.66 | 430,585 | 64,947 | 46.0232 |
News, Short Squeeze, Breakout and More Instantly...
-
Three clinical studies demonstrated serdexmethylphenidate (SDX), KemPharm’s prodrug of d-methylphenidate (d-MPH), yielded significantly lower abuse-related effects compared to d-MPH CELEBRATION, Fla., June 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (K...
-
Arimoclomol is an NDA-stage, revenue-generating investigational drug candidate being developed for the treatment of Niemann-Pick disease type C (NPC), a rare progressive neurodegenerative disease KemPharm plans to refile the New Drug Application (NDA) for arimoclomol in NPC with...
-
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, May 12, 2022, at 5:00 p.m. ET Filed Investigational New Drug (IND) application with U.S. Food and Drug Administration (FDA) for KP1077, a serdexmethylphenidate (SDX)-based product candidate for i...